- Home
- MCR vs AQST Comparison
MCR vs AQST Comparison
Compare MCR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- AQST
- Stock Information
- Founded
- MCR 1989
- AQST 2004
- Country
- MCR United States
- AQST United States
- Employees
- MCR N/A
- AQST N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- MCR Finance
- AQST Health Care
- Exchange
- MCR Nasdaq
- AQST Nasdaq
- Market Cap
- MCR 266.0M
- AQST 285.4M
- IPO Year
- MCR N/A
- AQST 2018
- Fundamental
- Price
- MCR $6.39
- AQST $3.01
- Analyst Decision
- MCR
- AQST Strong Buy
- Analyst Count
- MCR 0
- AQST 8
- Target Price
- MCR N/A
- AQST $10.38
- AVG Volume (30 Days)
- MCR 66.7K
- AQST 2.0M
- Earning Date
- MCR 01-01-0001
- AQST 03-05-2025
- Dividend Yield
- MCR 8.52%
- AQST N/A
- EPS Growth
- MCR N/A
- AQST N/A
- EPS
- MCR 0.38
- AQST N/A
- Revenue
- MCR N/A
- AQST $58,900,000.00
- Revenue This Year
- MCR N/A
- AQST $18.44
- Revenue Next Year
- MCR N/A
- AQST N/A
- P/E Ratio
- MCR $16.61
- AQST N/A
- Revenue Growth
- MCR N/A
- AQST 22.56
- 52 Week Low
- MCR $5.63
- AQST $2.24
- 52 Week High
- MCR $6.70
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- MCR 52.03
- AQST 43.29
- Support Level
- MCR $6.34
- AQST $2.95
- Resistance Level
- MCR $6.46
- AQST $3.21
- Average True Range (ATR)
- MCR 0.05
- AQST 0.20
- MACD
- MCR -0.01
- AQST 0.02
- Stochastic Oscillator
- MCR 27.78
- AQST 18.42
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.